NO141161C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive morfinanderivater - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive morfinanderivaterInfo
- Publication number
- NO141161C NO141161C NO750529A NO750529A NO141161C NO 141161 C NO141161 C NO 141161C NO 750529 A NO750529 A NO 750529A NO 750529 A NO750529 A NO 750529A NO 141161 C NO141161 C NO 141161C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutic active
- morphinan derivatives
- analogy procedure
- analogy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Paper (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5391870 | 1970-06-20 | ||
| JP394571A JPS5314558B1 (no) | 1971-02-02 | 1971-02-02 | |
| JP541371 | 1971-02-09 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO750529L NO750529L (no) | 1971-12-21 |
| NO141161B NO141161B (no) | 1979-10-15 |
| NO141161C true NO141161C (no) | 1980-01-23 |
Family
ID=27276046
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO2296/71A NO132279C (no) | 1970-06-20 | 1971-06-18 | |
| NO750529A NO141161C (no) | 1970-06-20 | 1975-02-18 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive morfinanderivater |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO2296/71A NO132279C (no) | 1970-06-20 | 1971-06-18 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3786054A (no) |
| BE (1) | BE768710A (no) |
| CA (1) | CA919668A (no) |
| DE (1) | DE2128607C3 (no) |
| DK (1) | DK137955B (no) |
| ES (1) | ES392421A1 (no) |
| FR (1) | FR2100799B1 (no) |
| GB (1) | GB1301243A (no) |
| NO (2) | NO132279C (no) |
| SE (1) | SE386894B (no) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1406882A (en) * | 1972-04-28 | 1975-09-17 | Leo Pharm Prod Ltd | Benzoic acid derivatives and benzisptjoaup'e 1.1 dopxode derovatoves |
| US3919237A (en) * | 1972-07-07 | 1975-11-11 | Hoffmann La Roche | Preparation of isomorphinan derivative |
| JPS52136176A (en) * | 1976-03-23 | 1977-11-14 | Bristol Myers Co | Method of improving 144hydroxymorphinan derivatives |
| US4058531A (en) * | 1976-03-23 | 1977-11-15 | Bristol-Myers Company | Process for the preparation of 14-hydroxymorphinan derivatives |
| EP2987788A1 (en) | 2002-05-17 | 2016-02-24 | Taiwanj Pharmaceuticals Co., Ltd. | Opioid and opioid-like compounds and uses thereof |
| CN101993417B (zh) * | 2009-08-10 | 2014-09-24 | 北京利乐生制药科技有限公司 | 磷酸二甲啡烷的稳定晶型 |
| CN102241630A (zh) * | 2011-05-20 | 2011-11-16 | 杭州保灵集团有限公司 | 一种镇咳嗽药磷酸二甲啡烷的制备方法 |
| CN103288731A (zh) * | 2013-06-03 | 2013-09-11 | 四川百利药业有限责任公司 | 一种磷酸二甲啡烷中间体的制备方法 |
| CN108299301A (zh) * | 2018-03-12 | 2018-07-20 | 合肥医工医药有限公司 | 一种制备高纯度二甲啡烷的方法 |
| CN108484502A (zh) * | 2018-03-12 | 2018-09-04 | 合肥医工医药有限公司 | 一种制备磷酸二甲啡烷的方法 |
| CN108383788A (zh) * | 2018-03-27 | 2018-08-10 | 合肥医工医药有限公司 | 一种二甲啡烷异构体的制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1093029A (fr) * | 1952-12-08 | 1955-04-29 | Hoffmann La Roche | Procédé pour la préparation de dérivés de morphinane |
-
1971
- 1971-06-03 CA CA114690A patent/CA919668A/en not_active Expired
- 1971-06-04 GB GB1301243D patent/GB1301243A/en not_active Expired
- 1971-06-08 US US00150900A patent/US3786054A/en not_active Expired - Lifetime
- 1971-06-09 DE DE2128607A patent/DE2128607C3/de not_active Expired
- 1971-06-17 FR FR7122067A patent/FR2100799B1/fr not_active Expired
- 1971-06-18 ES ES392421A patent/ES392421A1/es not_active Expired
- 1971-06-18 BE BE768710A patent/BE768710A/xx not_active IP Right Cessation
- 1971-06-18 SE SE7107938A patent/SE386894B/xx unknown
- 1971-06-18 DK DK300571AA patent/DK137955B/da not_active IP Right Cessation
- 1971-06-18 NO NO2296/71A patent/NO132279C/no unknown
-
1975
- 1975-02-18 NO NO750529A patent/NO141161C/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2100799B1 (no) | 1975-01-17 |
| ES392421A1 (es) | 1974-07-16 |
| FR2100799A1 (no) | 1972-03-24 |
| NO132279B (no) | 1975-07-07 |
| CA919668A (en) | 1973-01-23 |
| NO141161B (no) | 1979-10-15 |
| DK137955C (no) | 1978-11-06 |
| DE2128607C3 (de) | 1980-10-02 |
| DE2128607B2 (de) | 1980-02-07 |
| GB1301243A (no) | 1972-12-29 |
| NO132279C (no) | 1975-10-15 |
| BE768710A (fr) | 1971-11-03 |
| DK137955B (da) | 1978-06-12 |
| NO750529L (no) | 1971-12-21 |
| US3786054A (en) | 1974-01-15 |
| DE2128607A1 (de) | 1971-12-30 |
| SE386894B (sv) | 1976-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO145883C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7-methoxy-7-acylamino-cefalosporansyrederivater | |
| NO144885C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater | |
| NO141407C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater | |
| SE398877B (sv) | Forfarande for framstellning av 14-hydroxi-morfinanderivat | |
| SE385885B (sv) | Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat | |
| NO143575C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater | |
| NO142865C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive karbazoler | |
| NO138883C (no) | Fremgangsmaate for fremstilling av oksiranforbindelser | |
| NO142838C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater | |
| SE399701B (sv) | Forfarande for framstellning av hydroxyalkyldiamin | |
| NO141161C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive morfinanderivater | |
| NO143064C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner | |
| SE400551B (sv) | Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat | |
| SE394436B (sv) | Forfarande for framstellning av 7-halogen-linkomyciner | |
| NO142260C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater | |
| SE380273B (sv) | Forfarande for framstellning av tiopyrimidinderivat | |
| NO142077C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider | |
| SE392615B (sv) | Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat | |
| NO147485C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater | |
| NO145238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater | |
| SE385011B (sv) | Forfarande for framstellning av alfa-linkosaminider | |
| NO144110C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater | |
| SE384686B (sv) | Forfarande for framstellning av linkomycinderivat | |
| SE395699B (sv) | Forfarande for framstellning av kinuklidin-kinolinderivat | |
| NO146672C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cinnolinderivater |